492 related articles for article (PubMed ID: 16702611)
1. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.
Desar IM; Keuter M; Raemaekers JM; Jansen JB; van Krieken JH; van der Meer JW
Neth J Med; 2006 May; 64(5):136-40. PubMed ID: 16702611
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
3. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
[TBL] [Abstract][Full Text] [Related]
5. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
[TBL] [Abstract][Full Text] [Related]
9. [Gastric MALT lymphoma, clinical features].
Udvardy M
Orv Hetil; 1999 Feb; 140(6):291-4. PubMed ID: 10071508
[TBL] [Abstract][Full Text] [Related]
10. [The gastric MALT lymphoma. An unforeseen model for studying the pathogenesis of the lymphomas].
Savio A
Recenti Prog Med; 2009 Jun; 100(6):311-21. PubMed ID: 19708303
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
12. The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients.
Nakase H; Okazaki K; Ohana M; Ikeda K; Uchida K; Uose S; Itoh T; Iwano M; Watanabe N; Yazumi S; Kawanami C; Inoue F; Chiba T
Endoscopy; 2002 Apr; 34(4):343-6. PubMed ID: 11932795
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
Okiyama Y; Matsuzawa K; Hidaka E; Sano K; Akamatsu T; Ota H
Pathol Int; 2005 Jul; 55(7):398-404. PubMed ID: 15982214
[TBL] [Abstract][Full Text] [Related]
14. Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.
Iwai H; Nakamichi N; Nakae K; Konishi M; Inaba M; Hoshino S; Baba S; Amakawa R
Laryngoscope; 2009 Aug; 119(8):1491-4. PubMed ID: 19504556
[TBL] [Abstract][Full Text] [Related]
15. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
[TBL] [Abstract][Full Text] [Related]
16. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A
Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654
[TBL] [Abstract][Full Text] [Related]
17. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
Martinelli G; Laszlo D; Ferreri AJ; Pruneri G; Ponzoni M; Conconi A; Crosta C; Pedrinis E; Bertoni F; Calabrese L; Zucca E
J Clin Oncol; 2005 Mar; 23(9):1979-83. PubMed ID: 15668468
[TBL] [Abstract][Full Text] [Related]
18. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
Delchier JC
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
Kume K; Hirakoba M; Murata I; Yoshikawa I; Otsuki M
Am J Gastroenterol; 2001 Sep; 96(9):2796-7. PubMed ID: 11569719
[No Abstract] [Full Text] [Related]
20. [Helicobacter pylori update].
Buffet C
Bull Acad Natl Med; 2003; 187(6):1095-103; discussion 1103-5. PubMed ID: 14978870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
